|
Feb 18
|
Valneva hits 2024 sales target but plans lower cash burn in 2025
|
|
Feb 18
|
Valneva Reports Preliminary Unaudited 2024 Revenue and Cash and Provides 2025 Outlook
|
|
Feb 17
|
Bavarian Nordic scoops FDA approval for chikungunya vaccine in adults and teens
|